|
|
||||||||




* Department of Pathology, Harbor-UCLA Medical Center, Torrance, California 90509;
Faculté de Médecine de Brest, Laboratoire de Biochimie-EA948, 29285, Brest, France 29285;
Division of Molecular Toxicology, 1 MM, Karolinska Institut, S-17177 Stockholm, Sweden; and
§ Liver Study Unit, The Veterans Affairs Medical Center, University of Nebraska College of Medicine, Omaha, Nebraska 68105
The purpose of this investigation was to assess the effect of chlormethiazole treatment on liver damage in the experimental rat intragastric ethanol-feeding model of alcoholic liver disease. Chlormethiazole has been used in the treatment of alcoholic withdrawal and has been shown to inhibit cytochrome P4502E1. Since treatment of experimental alcoholic liver disease with CYP2E1 inhibitors had an ameliorating effect on liver injury in the rat, chlormethiazole was used to see if it had a similar effect. Rats fed ethanol for 2 months had significantly less liver injury when chlormethiazole was added to the diet, fed intragastrically. The CYP2E1 apoprotein levels, which were increased by ethanol feeding, were also increased when chlormethiazole was fed with ethanol. Chlormethiazole inhibited the increase in the ethanol-induced CYP2E1 activity in vivo, as measured by chlorzoxazone 6-hydroxylation, but did not affect the level of CYP2E1 apoprotein. Likewise, the reduction in proteasome proteolytic enzyme activity produced by ethanol feeding was blunted in chlormethiazole-fed rats. These results support the conclusion that chlormethiazole treatment partially protects the liver from injury by inhibiting CYP2E1 activity in vivo.
This article has been cited by other articles:
![]() |
A. M. Karinch, J. H. Martin, and T. C. Vary Acute and chronic ethanol consumption differentially impact pathways limiting hepatic protein synthesis Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E3 - E9. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and A. I. Cederbaum S-Adenosyl-L-methionine Attenuates Hepatotoxicity Induced by Agonistic Jo2 Fas Antibody following CYP2E1 Induction in Mice J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 44 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu and A. I. Cederbaum Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G674 - G684. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, L. Wang, Z. Song, J. T. Saari, C. J. McClain, and Y. J. Kang Zinc Supplementation Prevents Alcoholic Liver Injury in Mice through Attenuation of Oxidative Stress Am. J. Pathol., June 1, 2005; 166(6): 1681 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. J. Ronis, S. Korourian, M. Zipperman, R. Hakkak, and T. M. Badger Dietary Saturated Fat Reduces Alcoholic Hepatotoxicity in Rats by Altering Fatty Acid Metabolism and Membrane Composition J. Nutr., April 1, 2004; 134(4): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-D. Wang Retinoids and Alcohol-Related Carcinogenesis J. Nutr., January 1, 2003; 133(1): 287S - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Stickel, D Schuppan, E G Hahn, and H K Seitz Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut, July 1, 2002; 51(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |